跳至主要内容
临床试验/ISRCTN18110844
ISRCTN18110844进行中(未招募)未知

Cerebral mechanisms of acceptance and commitment therapy for neuropathic pain: a longitudinal randomised controlled neuroimaging trial

niversity of Liverpool0 个研究点目标入组 60 人开始时间: 2021年7月16日最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age 18 years or older, who have normal or corrected to normal vision and hearing by having a visual acuity of at least decimal 0.5 (6/12) measured on the Snellen scale (e.g., without metal-rimmed glasses or hearing aids)
  • 2. Willing to participate in the study and complete the scientific protocol
  • 3. People with type 1 or type 2 diabetes, with a glycated hemoglobin (HbA1c) level =11% at the screening visit, will be considered eligible to participate in the study

排除标准

  • 1. Current or planned hospitalisation during the period of study
  • 2. Patients not giving consent to participate
  • 3. Patients who cannot communicate fluently in English
  • 4. Unable, in the opinion of the research investigator, to comply or adhere to the requirements of the study. This may include, for example, an inability to understand the written documentation for the study
  • 5. A history of serious head injury, brain surgery or brain injury
  • 6. A history of neurological disease or psychiatric disorder which would negate involvement in the study. For example, Alzheimer's disease, Huntington’s Disease, Epilepsy, Parkinson Disease, large territory cerebrovascular accidents, severe depression, schizoaffective disorders, current under active therapy in psychiatric services
  • 7. Patients that have any underlying medical condition that in the opinion of the investigator will interfere with the study findings. For example: Patients with renal impairment, or hypothyroidism or hyperthyroidism; patients with a previous or current problem of primary or tertiary hyperparathyroidism, hypercalcemia, psychiatric disorder, alcohol dependency, hepatitis B or C, HIV infection or peripheral neuropathy due to a non-diabetic cause; pregnant; patients participating in any other interventional research trial, will be excluded from the study

研究者

发起方
niversity of Liverpool

相似试验